These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39022723)

  • 1. Evaluation of resazurin phenoxazine dye as a highly sensitive cell viability potency assay for natural killer cell-derived extracellular vesicle-based cancer biotherapeutics.
    St-Denis-Bissonnette F; Qiu S; Cummings SE; Kirkby M; Haile Y; Wassmer S; Muradia G; Mehic J; Stalker A; Shrestha A; Ardolino M; Lee SH; Burger D; Wang L; Lavoie JR
    J Extracell Biol; 2024 Jul; 3(7):e166. PubMed ID: 39022723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells.
    Wu CH; Li J; Li L; Sun J; Fabbri M; Wayne AS; Seeger RC; Jong AY
    J Extracell Vesicles; 2019; 8(1):1588538. PubMed ID: 30891164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer.
    Zhao J; Schlößer HA; Wang Z; Qin J; Li J; Popp F; Popp MC; Alakus H; Chon SH; Hansen HP; Neiss WF; Jauch KW; Bruns CJ; Zhao Y
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualification of a flow cytometry-based method for the evaluation of
    Raimo M; Zavoianu AG; Meijs W; Scholten P; Spanholtz J
    Heliyon; 2024 Jan; 10(2):e24715. PubMed ID: 38304826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
    St-Denis-Bissonnette F; Cummings SE; Qiu S; Stalker A; Muradia G; Mehic J; Mediratta K; Kaczmarek S; Burger D; Lee SH; Wang L; Lavoie JR
    J Extracell Vesicles; 2023 Dec; 12(12):e12387. PubMed ID: 38054534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
    Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells.
    Jong AY; Wu CH; Li J; Sun J; Fabbri M; Wayne AS; Seeger RC
    J Extracell Vesicles; 2017; 6(1):1294368. PubMed ID: 28326171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of circulating extracellular vesicles with altered expression and function during pregnancy.
    Nardi Fda S; Michelon TF; Neumann J; Manvailer LF; Wagner B; Horn PA; Bicalho Mda G; Rebmann V
    Immunobiology; 2016 Jul; 221(7):753-60. PubMed ID: 27005781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations.
    Nathani A; Sun L; Khan I; Aare M; Bagde A; Li Y; Singh M
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.
    Matchett EC; Kornbluth J
    Front Immunol; 2023; 14():1265101. PubMed ID: 37818374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases.
    He S; Su L; Hu H; Liu H; Xiong J; Gong X; Chi H; Wu Q; Yang G
    Front Immunol; 2023; 14():1328094. PubMed ID: 38239346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
    Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
    Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer.
    Yang C; Qian C; Zheng W; Dong G; Zhang S; Wang F; Wei Z; Xu Y; Wang A; Zhao Y; Lu Y
    Phytomedicine; 2024 Jan; 123():155180. PubMed ID: 38043385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
    Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
    J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
    Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N
    J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy.
    Lu YC; Ho CH; Hong JH; Kuo MC; Liao YA; Jaw FS; Cheng JC; Huang CY; Chang KP; Chen CH; Lin JA; Hsiao A; Kung HN
    Mol Oncol; 2023 Aug; 17(8):1613-1627. PubMed ID: 36931723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18.
    Aarsund M; Segers FM; Wu Y; Inngjerdingen M
    Cancer Immunol Immunother; 2022 Sep; 71(9):2227-2238. PubMed ID: 35119498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.